2026 Course Highlights
Return to Update in Hospital Medicine homepage⇒
ADDICTION MEDICINE
- Alcohol withdrawal: managing severe and refractory cases safely
- Phenobarbital for alcohol withdrawal: ready for prime time?
- Buprenorphine microdosing: smoother inductions for hospitalized patients
- Long-acting buprenorphine starts in the hospital: practical workflows that work
- Oral or injectable naltrexone: which patients benefit most from each approach?
- Harm reduction on discharge: strategies to prevent post-hospital overdose
- Treating pain in patients with substance use disorders without undertreating or overcorrecting
- Can addiction treatment during hospitalization save lives and reduce readmissions?
- Addiction consult services in the hospital: do they change outcomes?
- Stimulant use disorder is everywhere. What can hospitalists actually do?
- Xylazine, fentanyl, and the evolving overdose epidemic: what clinicians are missing
- Beyond opioids: emerging substances and adulterants hospitalists need to recognize
- Managing withdrawal in the era of polysubstance use
CARDIOVASCULAR
- Quadruple GDMT in heart failure: how fast should we really go?
- Shorter, simpler, safer? The evolving world of DAPT de-escalation
- Beta-blockers after MI: still standard of care or ready for retirement?
- How low can you go? New transfusion thresholds in acute coronary syndromes
- HFpEF enters the GLP-1 era
- Finerenone joins the HFpEF lineup: practice-changing or overhyped?
- Beating diuretic resistance: practical strategies for the volume-overloaded patient
- Atrial fibrillation in 2026: does rhythm control finally win?
- The subclinical AF dilemma: who needs anticoagulation?
- Elevated troponin outside ACS: when to worry and when to walk away
- SGLT2 inhibitors during acute illness: stop reflexively holding them?
- GLP-1 agonists in hospitalized patients: continue, pause, or prescribe?
- Troponin leaks, type 2 MI, and diagnostic gray zones: practical bedside decision-making
- Syncope, arrhythmias, and near misses: recognizing the cardiac patient who cannot wait
DERMATOLOGY
- Cellulitis or something else? Avoiding the most common inpatient skin misdiagnoses
- Swollen red leg showdown: cellulitis vs. venous stasis and other mimics
- Skin and soft tissue infections: how short can antibiotic courses safely go?
- Rash decisions: can’t-miss drug reactions in hospitalized patients
- When the skin tells the story: cutaneous clues to systemic disease
- Stevens-Johnson syndrome and TEN: recognizing life-threatening reactions early
- The antibiotics most likely to trigger severe dermatologic reactions
- “Can this wait until clinic?” Knowing when dermatology should see the patient now
- Pressure injury, skin failure, or neglect? Navigating a common inpatient dilemma
- Inpatient dermatology pearls every hospitalist should know
DIAGNOSTICS
- Coronary CTA vs. cath lab: are we entering a new era?
- ECGs you cannot afford to miss
- Chest X-ray misses that change management
- Rapid-fire diagnostic unknowns: electrolytes, liver, and heme
- Contrast or no contrast? Smarter imaging starts here
- Incidentalomas everywhere: what needs follow-up?
- Less testing, better care: the new diagnostic stewardship
- POCUS in 2026: essential tool or overused toy?
- A.I. reads the scan: should you trust it?
ENDOCRINE
- SGLT2 inhibitor complications: euglycemic DKA, UTIs, and perioperative risk
- Difficult inpatient hyperglycemia cases: practical management strategies
- New inpatient hyperglycemia management guidelines
- Metformin in hospitalized patients: too risky or underused?
- Adrenal insufficiency: whom to treat and how to taper steroids safely
- A practical approach to adrenal incidentalomas
- Pheochromocytoma: recognizing the zebra before it charges
- GLP-1 agonists in hospitalized patients: aspiration risk, ileus, and perioperative management
- Diabetes technology at the bedside: pumps, sensors, and closed-loop systems
- Stress-dose steroids: who actually needs them?
- Thyroid labs in acute illness: when not to overreact
GASTROINTESTINAL
- Hepatorenal syndrome in 2026: diagnosis, terlipressin, and beyond
- Covert hepatic encephalopathy: the cirrhosis complication you are probably missing
- New guidelines for spontaneous bacterial peritonitis treatment and prophylaxis
- Managing bleeding and thrombosis in cirrhosis
- Smarter triage for GI bleeds: new risk scores in practice
- Updates in upper and lower GI bleed management
- Upper GI bleed: does earlier endoscopy improve outcomes?
- Restarting anticoagulation after GI bleeding: how soon is too soon?
- Fluid resuscitation in acute pancreatitis: less is more
- Necrotizing pancreatitis: timing is everything
- Urgent and nonurgent indications for ERCP
- Preventing post-ERCP pancreatitis: what actually works?
- GLP-1 agonists and endoscopy risk: real concern or overreaction?
- MASLD/MASH: what hospitalists need to know
- Acute alcoholic hepatitis: updates in steroids, prognostication, and transplant eligibility
- The crashing cirrhotic patient: practical inpatient management pearls
GERIATRICS
- Delirium prevention: an ounce of prevention is worth a pound of cure
- Beyond sitters and restraints: practical nonpharmacologic delirium strategies
- Haloperidol and QTc monitoring: are we over checking?
- Risk-stratified use of antipsychotics for delirium
- Frailty: the inpatient risk factor hiding in plain sight
- Deprescribing at discharge: what medications should not come home?
- Hospitalization-associated disability: prevention starts on day one
- Managing dementia-related behaviors without restraints or oversedation s
HEMATOLOGY
- Clotting, bleeding, and everything in between: practical inpatient hematology
- Hypercoagulable workups: who needs one?
- Thrombocytopenia on the wards: avoiding the common diagnostic traps
- Inpatient anemia made practical: when to work up, transfuse, or wait
- Unprovoked VTE: is lifelong anticoagulation always the answer?
- “Provoked” vs. “unprovoked” VTE: time to rethink the terminology?
- Low-risk PE: who can safely avoid admission?
- Cancer-associated thrombosis: is low-dose apixaban ready for prime time?
- DOAC showdown: does one agent truly come out on top?
- DOACs in obesity and CKD: what does the latest evidence support?
- Myelodysplastic syndrome hiding in plain sight
- Iron deficiency without anemia: clinically meaningful or over diagnosed?
- Thrombotic microangiopathies: recognizing the hematologic emergency early
- Anticoagulation in thrombocytopenia: how low is too low?
- Heparin-induced thrombocytopenia in 2026: avoiding overdiagnosis and undertreatment
- Hospital-acquired anemia: can we prevent the drop?
- New guidelines for management of upper extremity DVT
INFECTIOUS DISEASES
- Antibiotic selection: practical inpatient approach
- When to consult ID for bacteremia
- IV-to-PO transitions: evidence-based strategies
- MSSA bacteremia: new data
- HIV screening and PrEP from the inpatient setting
- MRSA pneumonia: who needs coverage?
- CRP-guided decisions in community acquired pneumonia
- C. difficile: prevention, transmission, and treatment updates
- Fecal microbiota therapy: expanding role
- ESBL infections: risk and management
- IDSA diabetic foot infection updates
- Oral step-down therapy for bacteremia: how far can we go?
- Rapid diagnostics (PCR panels): do they improve outcomes or just costs?
- Antimicrobial stewardship in the era of resistance: what actually works
NEUROLOGY
- Stroke imaging: choosing the right modality
- Blood pressure targets in acute stroke
- Thrombolysis: expanding windows and new agents
- Thrombectomy: patient selection updates
- Anticoagulation after stroke: timing and safety
- Syncope: diagnostic and risk stratification tools
- Delirium vs. neurologic emergency: avoiding missed diagnoses
- Post-stroke anticoagulation timing: emerging trial data
- Factor XI inhibitors: new agents for secondary stroke prevention
PALLIATIVE CARE
- Which hospitalized patients benefit most from palliative care?
- Patient-centered strategies for serious illness conversations
- Best practices for leading family meetings
- Primary palliative care skills every hospitalist should master
- Managing non-pain symptoms at the end of life
- Goals-of-care discussions in the ICU: what actually works?
PERIOPERATIVE MEDICINE
- AHA perioperative guidelines: what hospitalists need to know
- GLP-1 agonists and SGLT2 inhibitors in the perioperative setting
- Updates on perioperative aspirin, statins, beta-blockers, and ACE inhibitors
- To hold or not to hold? The latest evidence in perioperative medication management
- Frailty as a predictor of perioperative risk
- Reducing pulmonary complications after surgery
- Perioperative anticoagulation: who needs bridging?
- Prehabilitation before surgery: does it improve outcomes?
- Postoperative troponin elevations: what should hospitalists do?
- Perioperative management of patients on chronic opioids and buprenorphine
PREGNANCY
- HELLP me: managing medical complications in pregnant and postpartum patients
- Best practices for hypertension management during and after pregnancy
- Risks, benefits, and contraindications to radiologic studies in pregnancy
- Periprocedural management of pregnant patients
- Treatment guidelines for UTI in pregnancy
- Postpartum hypertension and cardiomyopathy: when should hospitalists worry?
- Pulmonary embolism in pregnancy: evolving diagnostic and treatment strategies
- Managing severe infection and sepsis in pregnant patients
PSYCHIATRY
- Practical approaches to personality disorders in the hospital
- Inpatient management of psychiatric medications
- Diagnostic yield of neuroimaging in common psychiatric presentations
- Capacity assessment: can this patient make their own decisions?
- Agitation in the medically ill patient: safest evidence-based approaches
- Catatonia in hospitalized patients: often missed, highly treatable
- Avoiding medication interactions between psychiatric and medical therapies
PULMONARY/CRITICAL CARE
- COPD exacerbations: steroids and antibiotics
- Oxygen strategies: high-flow vs. noninvasive ventilation
- Sepsis management: current best practices
- Steroids in sepsis: who benefits?
- ICU sedation: propofol vs. dexmedetomidine
- Fluid stewardship in sepsis: less is more?
- Noninvasive ventilation in hypercapnia: who truly benefits
RENAL
- CKD progression: GLP-1, SGLT2i, and finerenone
- AKI: diagnostic and management updates
- Dialysis access and inpatient considerations
- Electrolyte management pearls
- Contrast nephropathy: myth vs. reality
- Acute-on-chronic kidney injury: prognostication and management
- Potassium binders: expanded inpatient use
RHEUMATOLOGY
- Preventing gout flares after starting urate-lowering therapy
- See the halo, skip the biopsy: diagnosing giant cell arteritis with ultrasound
- When should hospitalists call rheumatology?
- Dual therapy for lupus nephritis: steroids plus immunomodulators for active disease
- Crystal arthritis in hospitalized patients: septic joint or gout flare?
- Immune checkpoint inhibitor rheumatic toxicities: what hospitalists need to recognize
- ANCA-associated vasculitis: recognizing rapidly progressive disease early
- Macrophage activation syndrome and HLH: can’t-miss inflammatory emergencies
BEST PRACTICES
- Pain management in hospitalized patients
- Patient-directed discharges
- Discharge timing: does before noon matter?
- Social determinants of health and the hospitalist
- PRN antihypertensives: time to retire a common hospital practice?
- Hospital-acquired infections are not equal across communities
- Reducing administrative burden and burnout in hospital medicine
- Improving diagnostic excellence and reducing cognitive bias at the bedside
- Reducing low-value care: what to stop doing now
- Capacity and high-risk discharges: medico-legal updates
- Incidentalomas: when to work up vs. defer
- Boarding and throughput: evidence-based operational strategies
Return to Update in Hospital Medicine homepage⇒